Calithera’s Kuriakose to head oncology at Terns
Plus: Christine Foster named CBO at hC, and updates from Meliora, Seismic and ClavystBio
Terns Pharmaceuticals Inc. (NASDAQ:TERN) hired Emil Kuriakose as CMO of oncology, effective May 1. Kuriakose joins from Calithera Biosciences Inc. where he was CMO. Current CMO Kerry Russell will become CMO of the metabolic division, where she will lead NASH and obesity programs.
tRNA-based therapies company hC Bioscience Inc. hired Christine Foster as CBO. Foster was CBO at Mnemo Therapeutics S.A.S. and Metagenomi Inc...